Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40


APOE Genotype Effects on Intrinsic Brain Network Connectivity in Patients with Amnestic Mild Cognitive Impairment.

Wang Z, Dai Z, Shu H, Liao X, Yue C, Liu D, Guo Q, He Y, Zhang Z.

Sci Rep. 2017 Mar 24;7(1):397. doi: 10.1038/s41598-017-00432-0.


Modulation of APOE and SORL1 genes on hippocampal functional connectivity in healthy young adults.

Shen J, Qin W, Xu Q, Xu L, Xu J, Zhang P, Liu H, Liu B, Jiang T, Yu C.

Brain Struct Funct. 2017 Aug;222(6):2877-2889. doi: 10.1007/s00429-017-1377-3. Epub 2017 Feb 22.


Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer's Disease.

Almdahl IS, Lauridsen C, Selnes P, Kalheim LF, Coello C, Gajdzik B, Møller I, Wettergreen M, Grambaite R, Bjørnerud A, Bråthen G, Sando SB, White LR, Fladby T.

Front Aging Neurosci. 2017 Feb 7;9:9. doi: 10.3389/fnagi.2017.00009. eCollection 2017.


Connectivity Disruption, Atrophy, and Hypometabolism within Posterior Cingulate Networks in Alzheimer's Disease.

Mutlu J, Landeau B, Tomadesso C, de Flores R, Mézenge F, de La Sayette V, Eustache F, Chételat G.

Front Neurosci. 2016 Dec 21;10:582. doi: 10.3389/fnins.2016.00582. eCollection 2016.


Regional tau deposition measured by [18F]THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer's disease.

Saint-Aubert L, Almkvist O, Chiotis K, Almeida R, Wall A, Nordberg A.

Alzheimers Res Ther. 2016 Sep 29;8(1):38.


Disrupted white matter integrity is associated with cognitive deficits in patients with amnestic mild cognitive impairment: An atlas-based study.

Liu D, Wang Z, Shu H, Zhang Z.

SAGE Open Med. 2016 Jun 14;4:2050312116648812. doi: 10.1177/2050312116648812. eCollection 2016.


Neurometabolic characteristics in the anterior cingulate gyrus of Alzheimer's disease patients with depression: a (1)H magnetic resonance spectroscopy study.

Guo Z, Zhang J, Liu X, Hou H, Cao Y, Wei F, Li J, Chen X, Shen Y, Chen W.

BMC Psychiatry. 2015 Dec 2;15:306. doi: 10.1186/s12888-015-0691-7.


Electroacupuncture Upregulates SIRT1-Dependent PGC-1α Expression in SAMP8 Mice.

Dong W, Quo W, Wang F, Li C, Xie Y, Zheng X, Shi H.

Med Sci Monit. 2015 Nov 4;21:3356-62.


Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment.

Knopman DS, Jack CR Jr, Lundt ES, Wiste HJ, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Roberts RO, Boeve BF, Jones DT, Petersen RC.

JAMA Neurol. 2015 Dec;72(12):1475-83. doi: 10.1001/jamaneurol.2015.2323.


Improving (18)F-Fluoro-D-Glucose-Positron Emission Tomography/Computed Tomography Imaging in Alzheimer's Disease Studies.

Knešaurek K.

World J Nucl Med. 2015 Sep-Dec;14(3):171-7. doi: 10.4103/1450-1147.163246.


Lateral Temporal Lobe: An Early Imaging Marker of the Presymptomatic GRN Disease?

Caroppo P, Habert MO, Durrleman S, Funkiewiez A, Perlbarg V, Hahn V, Bertin H, Gaubert M, Routier A, Hannequin D, Deramecourt V, Pasquier F, Rivaud-Pechoux S, Vercelletto M, Edouart G, Valabregue R, Lejeune P, Didic M, Corvol JC, Benali H, Lehericy S, Dubois B, Colliot O, Brice A, Le Ber I; Predict-PGRN study group.

J Alzheimers Dis. 2015;47(3):751-9. doi: 10.3233/JAD-150270.


Brain structural, functional, and cognitive correlates of recent versus remote autobiographical memories in amnestic Mild Cognitive Impairment.

Tomadesso C, Perrotin A, Mutlu J, Mézenge F, Landeau B, Egret S, de la Sayette V, Jonin PY, Eustache F, Desgranges B, Chételat G.

Neuroimage Clin. 2015 May 28;8:473-82. doi: 10.1016/j.nicl.2015.05.010. eCollection 2015.


White matter disruption at the prodromal stage of Alzheimer's disease: relationships with hippocampal atrophy and episodic memory performance.

Rémy F, Vayssière N, Saint-Aubert L, Barbeau E, Pariente J.

Neuroimage Clin. 2015 Jan 27;7:482-92. doi: 10.1016/j.nicl.2015.01.014. eCollection 2015.


Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.

Cerami C, Della Rosa PA, Magnani G, Santangelo R, Marcone A, Cappa SF, Perani D.

Neuroimage Clin. 2014 Dec 5;7:187-94. doi: 10.1016/j.nicl.2014.12.004. eCollection 2015.


Neurostatistical imaging for diagnosing dementia: translational approach from laboratory neuroscience to clinical routine.

Imabayashi E, Inoue T.

Neurosci Bull. 2014 Oct;30(5):755-64. doi: 10.1007/s12264-014-1464-x. Epub 2014 Sep 5. Review.


Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrum.

Roy K, Pepin LC, Philiossaint M, Lorius N, Becker JA, Locascio JJ, Rentz DM, Sperling RA, Johnson KA, Marshall GA.

J Alzheimers Dis. 2014;42(1):291-300. doi: 10.3233/JAD-131796.


Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition.

Toledo JB, Weiner MW, Wolk DA, Da X, Chen K, Arnold SE, Jagust W, Jack C, Reiman EM, Davatzikos C, Shaw LM, Trojanowski JQ; Alzheimer’s Disease Neuroimaging Initiative.

Acta Neuropathol Commun. 2014 Mar 6;2:26. doi: 10.1186/2051-5960-2-26.


MEG spectral analysis in subtypes of mild cognitive impairment.

López ME, Cuesta P, Garcés P, Castellanos PN, Aurtenetxe S, Bajo R, Marcos A, Delgado ML, Montejo P, López-Pantoja JL, Maestú F, Fernandez A.

Age (Dordr). 2014 Jun;36(3):9624. doi: 10.1007/s11357-014-9624-5. Epub 2014 Feb 16.


Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease.

Vandenberghe R, Adamczuk K, Dupont P, Laere KV, Chételat G.

Neuroimage Clin. 2013 Apr 6;2:497-511. doi: 10.1016/j.nicl.2013.03.014. eCollection 2013. Review.

Supplemental Content

Support Center